Santhera Pharmaceuticals Narrows H1 Attributable Loss Revenue ... - Marketscreener.com
SPHDF Stock | USD 9.42 0.00 0.00% |
Roughly 61% of Santhera Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Santhera Pharmaceuticals Holding pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Santhera Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Santhera Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Santhera Pharmaceuticals pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Santhera daily returns and investor perception about the current price of Santhera Pharmaceuticals Holding as well as its diversification or hedging effects on your existing portfolios.
Santhera |
Santhera Pharmaceuticals Narrows H1 Attributable Loss Revenue ... Marketscreener.com
Read at news.google.com
Santhera Pharmaceuticals Fundamental Analysis
We analyze Santhera Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Santhera Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Santhera Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
Santhera Pharmaceuticals is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Santhera Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Santhera Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Santhera Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Santhera Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Santhera Pharmaceuticals Related Equities
DSGN | Design Therapeutics | 6.75 | ||||
ANAB | AnaptysBio | 6.50 | ||||
MGTX | MeiraGTx Holdings | 5.56 | ||||
IDYA | Ideaya Biosciences | 4.37 | ||||
ZVSA | ZyVersa Therapeutics | 4.23 | ||||
KROS | Keros Therapeutics | 3.23 | ||||
BDRX | Biodexa Pharmaceticals | 2.80 | ||||
GHRS | GH Research | 1.24 | ||||
GNFT | Genfit | 0.58 | ||||
IVA | Inventiva | 0.46 | ||||
ACHL | Achilles Therapeutics | 0.87 | ||||
LEXX | Lexaria Bioscience | 4.04 |
Complementary Tools for Santhera Pink Sheet analysis
When running Santhera Pharmaceuticals' price analysis, check to measure Santhera Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Santhera Pharmaceuticals is operating at the current time. Most of Santhera Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Santhera Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Santhera Pharmaceuticals' price. Additionally, you may evaluate how the addition of Santhera Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |